Navigation Links
MabPlex International, Ltd. Opens New Phase III and Commercial Manufacturing Facility
Date:12/10/2018

MabPlex International, Ltd., a fully integrated Contract Development and Manufacturing Organization (CDMO) with sites in China and the United States, providing comprehensive (cell line) development, process characterization, conjugation optimization, cGMP manufacturing, and aseptic fill finish solutions for monoclonal antibody (mAb) and antibody-drug conjugate (ADC) therapeutics, announced the grand opening and ribbon-cutting ceremony for their new M2 manufacturing facility in Yantai, China. The opening ceremony took place on September 6, 2018.

This milestone will enhance MabPlex’s ability to deliver Phase III and commercial development and manufacturing solutions to clients in multiple global markets and expand the company's manufacturing operations to a total of approximately 750,000 ft²; with 400,000 ft² devoted specifically to cGMP execution.

The completed 'M2' facility includes six independent cell culture suites, four independent purification suites, and a cGMP warehouse. Each of the six cell culture suites will support up to two single-use bioreactors at volumes of up to 2,000L (with a maximum capacity of 24,000L).

"With a growing number of novel and increasingly complex drug constructs in early development pipelines and new targeted therapies, such as ADCs, in late stage development and moving to commercialization, there is a growing global demand for specialized CDMOs," said Jianmin Fang, Ph.D, Chairman and CEO of MabPlex International, Ltd.

The new facility was built in response to the growing, global, demand for biomanufacturing capacity and complies with all international manufacturing regulations.

“This new facility, along with the opening of our San Diego and Shanghai process development sites, will increase our capacity to meet the needs of our new and current clients as they progress to commercialization,” Fang added.

Earlier this year, MabPlex USA, a subsidiary of MabPlex International, Ltd., opened the company's new state of the art Process Development Center of Excellence located in La Jolla, CA (USA) near San Diego, CA (USA) with scale up capacity to 200L, offering world class expertise supporting cell line development, upstream and downstream process development, Antibody-drug Conjugate (ADC) development, analytical development and formulation development.

About MabPlex
MabPlex International, Ltd. was founded in 2013 and specializes in providing complete biologics development and manufacturing solutions. Our technical expertise allows us to provide effective solutions for monoclonal antibody and Antibody-drug Conjugate (ADC) therapeutics, from cell line development and process characterization, to conjugation optimization and cGMP manufacturing. MabPlex is committed to delivering quality solutions to our customers around the world.

Read the full story at https://www.prweb.com/releases/mabplex_international_ltd_opens_new_phase_iii_and_commercial_manufacturing_facility/prweb15976947.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
2. GeneCell International, Miami’s Preferred Cord Blood Laboratory, is Pleased to Announce That July is National Cord Blood Awareness Month
3. Miami’s Preferred Cord Blood Laboratory, GeneCell International, Partakes in North Shore Medical Center and Hialeah Hospital’s OB/GYN Symposium
4. The Zacks Analyst Blog Highlights: Eaton, Baxter International, Bio-Rad Laboratories, INSYS Therapeutics and Boston Scientific
5. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
6. Beautiful You Magazine Features Nerium International, Creator of Best-Selling NeriumAD Age-Defying Treatment
7. Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com
8. Vital Force Technology, a Division of Energy Tools International, Focuses on Manufacturers with New Product Services and Marketing Campaigns
9. NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations
10. Fujifilm Holdings to Acquire Cellular Dynamics International, Inc.
11. Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2019)... ... 2019 , ... Consumers are directing healthcare in many ways, ... changing as many services now exist for patients to order tests without a ... million in 2018, according to Kalorama Information’s new report, The Direct-To-Consumer Testing ...
(Date:1/15/2019)... ... January 15, 2019 , ... Personalized treatment plans may extend life expectancy for ... a new study published in the journal Radiology. , Kidney, or renal, tumors ... a surgical procedure in which the tumor and part of the kidney are removed. ...
(Date:1/10/2019)... ... ... was adopted from a local shelter when he was around two years old. According ... weeks after he was adopted, he tore his right cruciate ligament. Though he had ... such a traumatic injury. , Sure enough, when Rascal was about nine years old, he ...
(Date:1/8/2019)... ... January 08, 2019 , ... The American Society of ... were named by a selection committee made up of industry leaders identified by the ... Development grants are mentored awards created to support ASGCT members designing transformative pilot studies ...
Breaking Biology Technology:
(Date:12/18/2018)... POWAY, Calif. (PRWEB) , ... December 18, 2018 , ... ... Dressage. He has been competing for many years however in 2006, he had ... a trot. It was determined that he suffered from cartilage degeneration in his ...
(Date:12/13/2018)... ... December 12, 2018 , ... ... Shah, one of the firm’s prominent Expert Consultants, was recently honored by the ... recognizes leaders who are working in pharmaceutical science, technology, engineering, or education and ...
(Date:12/13/2018)... Fla. (PRWEB) , ... December 12, 2018 , ... New ... preventing the growing problem of drowsy and distracted driving, one of the main causes ... under the guidance of Dr. Kanwal Gagneja , assistant professor of computer science, ...
Breaking Biology News(10 mins):